A report scopes out the global testosterone market by segmenting it by product type and active ingredients. The different TRT products are avinto patches, injections, creams/gels, gums/buccal adhesives, oral drug forms, and implants. The creams/gels segment, among them, accounts for a dominant share in the market due to the robust sales of branded formulations. In terms of growth rate, however, the injections product segment is slated to outshine others with more consumers buying the products as they are relatively cheap and can be self-administered. Among the different active ingredients, testosterone holds a sway over the market but is expected to face strong competition from other active ingredients such as testosterone undecanoate and testosterone cypionate in the upcoming years.
Trends and Opportunities
A major concern in the global testosterone replacement therapy market is the imminent patent expiration of some of the top products which will pave the way for lesser priced generics in the market. This is predicted to bring down revenues of dominant players significantly. The segment predicted to take maximum hit is the gels/cream TRT products, which now enjoys a dominant market share because of its ease of use and reduced side effects. Another factor bogging down the market is the possible risk of cardiovascular or metabolic disease resulting from the treatment of testosterone deficiency.
The blow dealt by the patent expirations to the global market for testosterone replacement therapy is expected to be somewhat mitigated by the growing instances of testosterone deficiency and a burgeoning geriatric population – a key target demographic for companies. Besides, rising awareness about testosterone replacement therapy (TRT) and unveiling of innovative testosterone replacement therapy technology such as spray-on and unmodified testosterone is also expected to propel sales and offset the loss to some extent. But overall, patent expirations will drag down revenues in the long run.
Global Testosterone Replacement Therapy Market: Regional Outlook
North America, powered by strong demand for advanced TRT products in the U.S., dominates the global testosterone replacement market by accounting for almost 84.0% share in it. In fact, the U.S. occupied about 95.0% of the North America market in 2015. Europe follows North America vis-à-vis market share. Other important markets are Asia Pacific, the Middle East and Africa (MEA), and Latin America. Asia Pacific is expected to exhibit speedy growth because of significantly higher healthcare investments. China and India hold out a solid potential for the TRT market. South Korea and Japan too will impact sales positively due to a growing population of geriatrics. In Latin America, Brazil is the primary TRT market with maximum share.
Companies Mentioned in Report
Prominent players in the global testosterone replacement therapy market are Allergan plc, Novartis AG, AbbVie, Inc., Endo Pharmaceuticals, Inc., Bayer AG, Eli Lilly and Company, Mylan N.V., and Pfizer, Inc.
Global Testosterone Replacement Therapy Market is segmented as:
Segmentation
Global Testosterone Replacement Therapy Market, by Product Type
Global Testosterone Replacement Therapy Market, by Active Ingredient Type
Global Testosterone Replacement Therapy Market, by Geography
This report gives you access to decisive data such as:
Key highlights of this report
Table of Content
1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
2.1. Global Testosterone Replacement Therapy: Market Snapshot
2.2. Global Testosterone Replacement Therapy Market Share, by Geography, 2015 & 2024 (E)
2.3. Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2015
2.4. Global Testosterone Replacement Therapy Market Revenue, by Active Ingredient, (US$ Mn), 2015
3. Global Testosterone Replacement Therapy Market – Industry Analysis
3.1. Introduction
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Increase in incidence of testosterone deficiency
3.2.1.2. Rise in geriatric population with high risk of testosterone deficiency
3.2.1.3. Growing awareness about testosterone replacement therapy
3.2.2. Restraints
3.2.2.1. High risk of side effects related to testosterone replacement therapy
3.2.2.2. Patent expiry of key drugs and entry of generics
3.2.3. Opportunities
3.2.3.1. Asia Pacific holds immense potential for testosterone replacement therapy
3.3. Market Attractiveness Analysis: Global Testosterone Replacement Therapy Market, by Geography, 2015
3.4. Pricing Analysis: Testosterone Replacement Therapy Market, by Product, (US$) 2015
3.5. Global Testosterone Replacement Therapy Market Revenue, by Product Type, (US$ Mn), 2014–2024
3.5.1. Overview
3.5.2. Global Creams/Gels Market Revenue, (US$ Mn), 2014–2024
3.5.3. Global Patches Market Revenue, (US$ Mn), 2014–2024
3.5.4. Global Injections Market Revenue, (US$ Mn), 2014–2024
3.5.5. Global Gums/Buccal Adhesives Market Revenue, (US$ Mn), 2014–2024
3.5.6. Global Implants Market Revenue, (US$ Mn), 2014–2024
3.5.7. Global Oral TRT Market Revenue, (US$ Mn), 2014–2024
3.6. Global Testosterone Replacement Therapy Market Revenue, By Active Ingredient, (US$ Mn), 2014–2024
3.6.1. Overview
3.6.2. Global Testosterone Market Revenue, (US$ Mn) 2014–2024
3.6.3. Global Methyl Testosterone Market Revenue, (US$ Mn) 2014–2024
3.6.4. Global Testosterone Undecanoate Market Revenue, (US$ Mn) 2014–2024
3.6.5. Global Testosterone Enanthate Market Revenue, (US$ Mn) 2014–2024
3.6.6. Global Testosterone Cypionate Market Revenue, (US$ Mn) 2014–2024
3.7. Competitive Landscape: Global Testosterone Replacement Therapy Market Share, by Key Players, 2015 (%)
3.8. Pipeline Analysis: Testosterone Replacement Therapy
3.9. TRT Technology Development Timeline
4. North America Testosterone Replacement Therapy Market Analysis
4.1. Key Trends Analysis
4.2. North America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
4.3. North America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024
5. Europe Testosterone Replacement Therapy Market Analysis
5.1. Key Trends Analysis
5.2. Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
5.3. Europe Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024
6. Asia Pacific Testosterone Replacement Therapy Market Analysis
6.1. Key Trends Analysis
6.2. Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
6.3. Asia Pacific Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024
7. Middle East and Africa (MEA) Testosterone Replacement Therapy Market Analysis
7.1. Key Trends Analysis
7.2. MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
7.3. MEA Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024
8. Latin America Testosterone Replacement Therapy Market Analysis
8.1. Key Trends Analysis
8.2. Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Product Type, (US$ Mn), 2014–2024
8.3. Latin America Testosterone Replacement Therapy (TRT) Market Revenue, by Active Ingredient, (US$ Mn), 2014–2024
9. Global Testosterone Replacement Therapy Market, Country Snippets
9.1. Global Testosterone Replacement Therapy Market Revenue, by Country, (US$ Mn), 2014–2024
9.2. U.S. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.3. Japan Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.4. Germany Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.5. U.K. Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.6. Canada Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.7. China Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.8. Brazil Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.9. Mexico Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
9.10. United Arab Emirates (UAE) Testosterone Replacement Therapy Market Revenue, (US$ Mn), 2014–2024
10. Company Profiles
10.1. AbbVie, Inc.
10.2. Allergan plc
10.3. Bayer AG
10.4. Endo Pharmaceuticals, Inc.
10.5. Eli Lilly and Company
10.6. Kyowa Kirin International plc
10.7. Mylan N.V.
10.8. Novartis AG
10.9. Pfizer, Inc.